Advancing sustainable HPV vaccination programs in Africa – EN

Participating Countries

• Opening Remarks – Welcome
  Dr. Patrick Amoth, EBS, Director General Health, Ministry of Health, Kenya
• Welcome note – Jhpiego Country Director Kenya
  Dr. Paul Nyachae, Jhpiego Country Director, Kenya
• Overview of CHIC Symposium Objectives
  Prof. Alex Vorsters, University of Antwerp
• Participants Introduction

Chairs:  Prof. Deborah Watson-Jones LSHTM, UK & Dr. Joan-Paula Bor-Maleny, NCC, Kenya

• Current Numbers: HPV disease prevalence and incidence across the AFRO region
  Dr. Safdar Nosheen, AFRO Regional office, World Health Organization
• HPV vaccination in the context of upcoming shifts in Gavi’s grant model  
  Ms. Emily Kobayashi, Gavi
• Q&A

Chairs: Dr. Edina Amponsah-Dacosta, University of Cape Town & Ms. Nayab Waheed, University of Antwerp

• Exploring service delivery strategies, their frequency and long-term coverage trends using school-based platforms.
  Uganda – Dr. Immaculate Ampaire, EPI Uganda
  Rwanda – Irene Mukanyandwi, EPI Rwanda
• Articulating the challenges: Country experiences improving service delivery through a lens of persistent challenges
  Kenya – Dr. Rose Jalang’o, NVIP, Kenya,
  The Gambia – Mrs. Mbayang Johm, HPV focal person, EPI The Gambia
  Senegal – Dr. Alassane Ndiaye, Ministère de la Santé et de l’Action sociale, Senegal
  Zimbabwe – Dr. Clara Mashrinigo, EPI Zimbabwe
• Discussion and Q&A
• Challenges and good practices for sustaining delivery after a MAC introduction: Nigeria’s experience towards cervical cancer elimination
  Mrs. Elizabeth Hassan, NPHCDA, Nigeria
• Q&A

Chairs: Dr. Cathy Ndiaye, PATH & Ms. Rosemary Njura Njogu, Jhpiego, Kenya

• Ensuring sustainable delivery for diverse populations, including settings with low school enrollment and fragile or conflict-affected areas
  Burkina Faso – Mr. Bakouan René Didace, EPI Burkina Faso
  Cote d’Ivoire – Dr. Innocent Massenon, EPI Cote d’Ivoire
  
  Plenary Input:
• Identification and enumeration of OOS girls and girls living in hard-to-reach areas – countries’ work overview
  Dr. Cathy Ndiaye, PATH moderating countries’ input (Burkina Faso, Kenya, Nigeria and Malawi)
• Discussion and Q&A
  

Chairs: Dr. Cathy Ndiaye, PATH & Ms. Rosemary Njura Njogu, Jhpiego, Kenya

• Synthesis of learnings on delivery and key takeaways
  Dr. Mercy Mvundura, PATH
  Dr. Ibrahima Leye, NITAG Senegal
  Mr. Henry Ssemakula, MoE Uganda
  Ms. Georgina Joachim Temba, EPI Tanzania
  Dr. Jacob Sakala, EPI Zambia
  Input from countries presented in earlier sessions
  
  

• Reflecting and Giving Feedback for Day 1
  Prof. Alex Vorsters, University of Antwerp

Chairs: Dr. Sambo Guemgo, WHO West & Central Africa & Dr. Scott LaMontagne, JSI

• Health Information Systems and Data for Action: Country examples
  Cameroon – Dr. Shalom Tchokfe, EPI Cameroon
  Rwanda – Dr Patrick Tuyishime, EPI Rwanda
  Tanzania – Dr. Furaha Kyesi, EPI Tanzania
• Q&A

Chairs: Dr. Christopher Morgan, Jhpiego & Dr. Rose Jalang’o, Head NVIP, Kenya

• Common challenges in preparing for the Gavi transition
  Kenya – Dr. Rose Jalang’o, Head NVIP, Kenya
  Côte d’Ivoire – Mr. Soussoubié Koffi, Côte d’Ivoire
• Financial sustainability for HPV vaccination
  Malawi – Ms. Brenda Mhone, EPI Malawi
  Zimbabwe – Dr. Clara Mashiringo, EPI Zimbabwe
• After Gavi: South Africa’s experience crafting a sustainable HPV vaccination program
  Ms. Phuti Mashiane, EPI South Africa
• Discussion and Q&A
  
• Panel Discussion on funding and financial sustainability
  Gavi – Ms. Emily Kobayashi, Gavi
  World Bank – Dr. Aneesa Arur, World Bank
  Gates Foundation – Dr. Tanjila Taskin, Gates Foundation
  

Chairs: Dr. Nelly Mugo, KEMRI, Kenya & Dr. Mary Carol Jennings, Jhpiego

• Context-responsive modelling to inform HPV vaccination strategies: from introduction, vaccine target expansion, to integration with screening
  Dr. Irene Man & Dr. Rachel Wittenauer, IARC
• HPV vaccine product landscape
  Mr. Paul Bloem, WHO
• Q&A

Facilitators: CHIC Secretariat (Dr. Ana Bolio, Ms. Nayab Waheed and Ms. Shana Kagan)

• Introduction
• Discussing and selecting top priority themes
• Voting for priority themes

Facilitators: CHIC Secretariat (Dr. Ana Bolio, Ms. Nayab Waheed and Ms. Shana Kagan)

• Rotating thematic group discussion
  • Participants engage in structured round table discussions on priority themes to surface country experiences, program challenges, and good practices. Each participant joins round table discussions of two of their top-ranked themes. Round table discussions explore actionable strategies to address common challenges by theme, and each group reports out highlights to the plenary.

• Discussion in country groups

CHIC Secretariat (Mrs. Elaine Charurat, Dr. Ana Bolio, Dr. Emilie Karafilakis (Francophone groups) & Dr. Ricardo Burdier (Francophone groups))

• Plenary Feedback from countries on their action items
• Plenary discussion and closing remarks

• HPV Vaccination Determinant in Cameroon: A Cross-Sectional Nationwide Health Workers Survey
  • Andreas Ateke Njoh
    
• Prevalence of Human Papillomavirus Type 16/18 Among Females Living in an Urban Area of the Democratic Republic of Congo
  • Marithe Ntumba Mukoka
    
• Formative insights to optimize the systematic medical visits, an integrated package of health services including HPV vaccination, in Côte d’Ivoire.
  • Rosine Addy Bomisso Mosso
    
• Using Geographic information System mapping for Evidence-Based Planning to Reach HPV vaccine Target Girls and Zero-Dose Children: Experience from Jigjiga Town, Ethiopia.
  • Habtamu Belete
    
• Reaching the unreached: Integrating HPV Vaccination into Community Based Health Platforms in Ethiopia.
  • Helen Negassi Tesfom
    
• Efficacy Of Quadrivalent Human Papillomavirus Vaccine Among Kenyan Adolescents And Young Adults Living With HIV Nine Years After Initial Vaccination
  • Lynda Myra Oluoch
    
• Leaving 22 million girls unprotected from HPV: Impact of adopting a single-age target with low vaccination coverage in Kenya
  • Valerian Mwenda
    
• Financing and Policy Dynamics in HPV Vaccine Uptake: Insights from Kenya’s Gavi Transition and Single-Dose Introduction
  • Mercy Kithure
    
• Integrating School Engagement And Facility-Based Screening To Strengthen HPV Vaccination In Kenya.
  • Jeniffer Namazzi
    
• Community-driven solutions for HPV vaccination: results from human-centered design in Malawi and Mozambique
  • Acacio Sabonete
    
• Laying the groundwork for adolescent-centred HPV services: Formative Insights from Stakeholder Consultations in Lagos and Kebbi States, Nigeria
  • Victor Abiola Adepoju
    
• Communication And Dialogue With Islamic Religious Scholars: A Focus Group Discussion To Enhance Human Papillomavirus Vaccine Awareness And Uptake In Northern Nigeria 
  • Mohammed Manga
    
• Using Routine Human Papillomavirus Vaccination Data to Guide High-Impact Community Outreach in Nigeria
  • Oluwasogo Kehinde Dada
    
• Financing Of Human Papillomavirus Vaccination In Africa: A Scoping Review
  • Kafayat Wemimo Aminu
    
• Overcoming Barriers To Human Papillomavirus Vaccine Uptake In Sierra Leone: Insights From Formative Research In Four Low-Performing Districts
  • Joan Koroma
    
• Improving uptake of HPV Vaccine: Challenges and strategies used to reach Out-of-School Adolescents in Tanzania
  • Linda Beatrice Mlunde
    
• Improved HPV Vaccination by co-designing a context-specific Integrated Health Service Delivery Package in Kebbi and Lagos State, Nigeria: Human-Centered Design Approach.
  • Angioha Pius
    
• Expanding HPV vaccine Programs to Older Adolescent Girls or Young Boys: Immunization Stakeholder Perspectives in 11 Low- and Middle-Income Countries
  • Soim Park
    
• Does a single-dose HPV vaccine regimen deliver program cost savings? Real-world evidence from Ethiopia
  • Mercy Mvundura